Kneat.com (KSI) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
24 Nov, 2025Executive summary
Annual recurring revenue grew 51% year-over-year in Q1 2025 to $63.5M, with total revenue up 37% to $14.7M and SaaS license revenue up 42% to $13.8M compared to Q1 2024.
Gross profit increased 38% year-over-year to $10.9M, with gross margin steady at 74%.
EBITDA improved to $5.9M from a loss of $0.5M in Q1 2024; Adjusted EBITDA was $2.3M, up from $0.6M.
Net income for Q1 2025 was $2.1M, compared to a net loss of $3.3M in Q1 2024; EPS was $0.02 versus $(0.04).
Leadership team expanded with a new Chief Product Officer and Chief Innovation Officer to drive product vision and growth.
Financial highlights
Q1 2025 revenue was $14.7M, up from $10.8M in Q1 2024.
SaaS license revenue reached $13.8M, a 42% increase year-over-year.
Gross profit was $10.9M, up 38% from the prior year, with gross margin at 74%.
Operating expenses were $12.3M, up 21% year-over-year, with sales and marketing at $5.1M and R&D at $4.7M.
Cash position at quarter-end was $74.1M, up from $58.9M at December 2024, mainly due to timing of annual subscription collections and $20M raised from public equity financing.
Outlook and guidance
Management remains confident in financial outlook, citing a growing, high-retention customer base and a strong balance sheet.
Enterprise and strategic accounts, which drive most ARR, continue to invest despite broader economic uncertainties.
Expansion into adjacent validation and documentation workflows is underway, broadening the platform's addressable market.
Continued focus on expanding enterprise-wide adoption and enhancing the Kneat Gx platform.
Latest events from Kneat.com
- Software revenue up 33% in 2025; ARR at $74.1m; targeting cash flow breakeven in 2026.KSI
Q4 202526 Feb 2026 - SaaS validation platform achieves 138% net revenue retention and targets $2B+ ARR in life sciences.KSI
Small-Cap Growth Virtual Investor Conference 20243 Feb 2026 - ARR rose 60% and gross margin reached 74% in Q2 2024, with strong SaaS and partner growth.KSI
Q2 20242 Feb 2026 - Aggressive drilling at Coyote begins soon, targeting high-grade uranium in a fully funded campaign.KSI
Emerging Growth Conference 8921 Jan 2026 - Digitized validation leader achieves rapid ARR growth and major efficiency gains for life sciences.KSI
Investor presentation21 Jan 2026 - Record Q3 revenue, ARR, and margin growth, with new global contracts and strong outlook.KSI
Q3 202415 Jan 2026 - High-growth validation software leader drives digital transformation in life sciences.KSI
Planet MicroCap Showcase: VEGAS 202527 Dec 2025 - Record SaaS-driven growth, high margins, and strong cash position support 2025 momentum.KSI
Q4 202416 Dec 2025 - Q2 revenue up 32%, ARR up 43%, with record SaaS growth and strong outlook for 2026.KSI
Q2 202523 Nov 2025